L.H. Camara Lopes works at Genoa Biotecnologia - especializada em genética molecular. Genoa/LPCM is a laboratory diagnostic services company result of melting Genoa Biotechnology SA, research company in molecular genetics since 2001 with the Surgical Pathology Laboratory of Molecular housed since 1980 in the Syrian Lebanese Hospital which is hung in 2013 to enable this partnership. The Group works on development and commercialization of tests for disease risk assessment, clinical decision support and referral for the best therapeutic program. Genoa / LPCM has developed a series of Molecular Diagnostics using state of the art technologies in molecular oncology. Available tests include sequencing and analysis of long gene mutations (such as BRCA1, BRCA2, TP53, PTEN, MLH1, MSH6, MSH2, E-cadherin, VHL, RET, and many others), and other high-end services.